Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer

January 15, 2020
Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma

NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …

News
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020
Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …

News
48721589102_164e25393b_b

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

January 15, 2020
Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …

News
6934974672_fd18b2ea20_b

Chinese coronavirus found in Thailand

January 14, 2020
Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand

The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …

News
shutterstock_512649

MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate

January 14, 2020
Manufacturing and Production, Sales and Marketing Incyte, morphosys, pharma, tafasitamab

MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a …

News
business-laptop-computer-money

Acasti’s shares plunge as new drug does not meet primary endpoint

January 14, 2020
Manufacturing and Production Acasti, Acasti Pharma, CaPre, Primary Endpoint, Shares

Acasti Pharma’s shares plunged by as much as 67% this week as its drug CaPre failed to meet its primary …

News
biogen_austria_238

Biogen picks up Pfizer’s Phase 1 therapy for Alzheimer’s symptoms in potential $700m deal

January 14, 2020
Manufacturing and Production, Sales and Marketing Alzheimer's, Biogen, Pfizer, pharma

Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop …

News
nhs_old_hospital_1

NHS to pioneer Novartis injection that reduces cholesterol

January 14, 2020
Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack

The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …

News
zytiga_outside

NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer

January 13, 2020
Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer

Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …

News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …

Feature

FDA approves Astellas injectable antifungal drug for newborns

January 13, 2020
Sales and Marketing Astellas, Atellas Pharma, FDA, fungal virsus

The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns. From Astellas, the new drug …

News
shutterstock_273326141

Eli Lilly to boost immunology portfolio with $1.1bn Dermira acquisition

January 13, 2020
Sales and Marketing Dermira, Eli Lilly, pharma

Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development …

News
flag-1267780_1280

Pakistan registers cases against 200 pharmaceutical companies

January 13, 2020
Sales and Marketing National Task Force, Pakistan, Pakistani Pharmaceuticals, corruption

The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has overall …

News

AstraZeneca to discontinue trial for heart disease drug Epanova

January 13, 2020
Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides

AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …

News
1201709115_133b3927a3_b

Bayer and Exscientia to work together on AI in cardiovascular and oncology drug discovery

January 10, 2020
Medical Communications Bayer, Exscientia, oncology

Bayer AG has partnered with Exscientia to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. …

News

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020
Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …

News
48612088061_36c0f87278_b

Idorsia reveals it is working with Neurocrine on new epilepsy drug deal

January 10, 2020
Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma

Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …

News

US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy

January 10, 2020
Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma

The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …

News
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …

News
merck-keytruda

MSD’s Keytruda chalks up bladder cancer approval in the US

January 9, 2020
Sales and Marketing Cancer, MSD, bladder cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has added another US approval to its repertoire with the news that FDA has awarded …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026